← All stocks

BMY vs GSK

Bristol-Myers Squibb Company Common Stock vs GSK plc American Depositary Shares (Each representing two Ordinary Shares). Side-by-side ACCE scores, valuation, profitability, and growth.

ACCE scores
BMY
GSK
Composite score
Out of 100
78
63
Growth
64
28
Value
88
81
Quality
83
88
Momentum
77
54
Valuation
BMY
GSK
Price
62.62
51.08
Market cap
127.91B
100.58B
Trailing P/E
13.79
15.94
Forward P/E
9.65
9.67
EV / EBITDA
9.68
9.34
Dividend yield
4.0%
3.6%
Profitability
BMY
GSK
ROE
46.6%
33.4%
Net margin
18.9%
14.5%
Debt / equity
2.44
1.03
Free cash flow
12.85B
5.82B
Growth
BMY
GSK
Revenue growth (YoY)
5.7%
5.3%
Earnings growth (YoY)
1.5%
-69.5%
Analyst target
66.71
59.33
See full analysis